4 1 f4dk01aug.txt 1 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 1. Name and Address of Reporting Person: David Knudson, 1661 Lakeview Circle, Ogden, UT 84403 2. Issuer Name and Ticker or Trading Symbol: ImmunoTechnology Corp ("IMNT") 3. IRS or Social Security Number of Reporting Person (Voluntary): 4. Statement for Month/Year: 8/2001 5. If Amendment, Date of Original (Month/Year): 6. Relationship of Reporting Person(s) to Issuer (Check all Applicable) ( ) Director (X) Officer, give title below (X) 10% Owner ( ) Other Title: Secretary/Treasurer 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person TABLE I NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED 1. Title of Security: Common Stock 2. Transaction Date (Month/Day/Year): 08/22/2001 3. Transaction Code: J 4. Securities Acquired (A) or Disposed of (D): Amount: (A) 1,013,942 5. Amount of Securities Beneficially Owned at End of Month: 2,131,615 6. Ownership Form: Direct (D) or Indirect (I): (D) 7. Nature of Indirect Beneficial Ownership: N/A TABLE II DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF OR BENEFICIALLY OWNED 1. Title of Derivative Security: 2. Conversion or Exercise Price of Derivative Security: 3. Transaction Date (Month/Day/Year): 4. Transaction Code: 5. Number of Derivative Securities Acquired (A) or Disposed of (D): 6. Date Exercisable and Expiration Date (Month/Day/Year): 7. Title and Amount of Underlying Securities: 8. Price of Derivative Security: 9. Number of Derivative Securities Beneficially Owned at End of Month: 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I): 11. Nature of Indirect Beneficial Ownership: Explanation of Responses: The securities were acquired in settlement of debt owed to Mr. Knudson totaling $31,685.79 in principal and interest. Signature of Reporting Person: /S/David Knudson Date: 9/6/2001